We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

11 hedge funds and large institutions have $1.15M invested in Eterna Therapeutics in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

104% more capital invested

Capital invested by funds: $566K → $1.15M (+$587K)

0.22% more ownership

Funds ownership: 0.27% → 0.49% (+0.22%)

0% more funds holding

Funds holding: 11 → 11 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Corient Private Wealth
Corient Private Wealth
Florida
+$597K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$33.7K
3
HF
HRT Financial
New York
+$17.2K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.33K
5
FFO
Fortitude Family Office
Arizona
+$1.09K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$33.8K
2
TRCT
Tower Research Capital (TRC)
New York
-$5.67K
3
EWA
EverSource Wealth Advisors
Alabama
-$127
4
Morgan Stanley
Morgan Stanley
New York
-$68
Name Holding Trade Value Shares
Change 		Change in
Stake
Corient Private Wealth
1
Corient Private Wealth
Florida
$1.05M +$597K +17,523 +100%
Vanguard Group
2
Vanguard Group
Pennsylvania
$43.1K +$33.7K +991 +222%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$28.3K +$4.33K +127 +16%
HF
4
HRT Financial
New York
$15K +$17.2K +505 New
SCA
5
Sippican Capital Advisors
Massachusetts
$12K – – –
BlackRock
6
BlackRock
New York
$984 – – –
FFO
7
Fortitude Family Office
Arizona
$965 +$1.09K +32 New
UBS Group
8
UBS Group
Switzerland
$720 +$817 +24 New
AssetMark Inc
9
AssetMark Inc
California
$160 – – –
Bank of America
10
Bank of America
North Carolina
$41 – – –
Morgan Stanley
11
Morgan Stanley
New York
$36 -$68 -2 -67%
BNP Paribas Financial Markets
12
BNP Paribas Financial Markets
France
$12 – – –
MA
13
Montag & Associates
Georgia
$10 – – –
AWM
14
Activest Wealth Management
Florida
$4 – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
– -$33.8K -1,234 Closed
TRCT
16
Tower Research Capital (TRC)
New York
– -$5.67K -207 Closed
EWA
17
EverSource Wealth Advisors
Alabama
– -$127 -5 Closed

ERNA Hedge Fund Activity: Q4 2025 in Review

11 of the 8,245 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2025, worth a combined $1.15M — up 104% from $566K a quarter earlier.

Fund positioning in ERNA was balanced in Q4 2025: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 1 trimmed.

The largest buyer was Corient Private Wealth, adding an estimated $597K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $33.8K sold.

  • 11 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $1.15M of Eterna Therapeutics stock for Q4 2025, up 104% quarter-over-quarter.
  • 3 funds opened new Eterna Therapeutics positions in Q4 2025 and 3 closed out, a net change of 0 holders.
  • The largest Eterna Therapeutics buyer in Q4 2025 was Corient Private Wealth, an estimated $597K added.
  • The largest Eterna Therapeutics seller in Q4 2025 was Susquehanna International Group, an estimated $33.8K sold.

Based on aggregated 13F filings for Q4 2025.